Nevro Corp. (NYSE: NVRO) was founded in 2006 and is headquartered in Redwood City, California, USA, with 308 full-time employees. It is a medical device company that specializes in spinal cord stimulators.
Nevro Corp. (NVRO):
Nevro is a medical device company that develops and commercializes a neuromodulation platform in the United States, Europe and Australia for the treatment of chronic pain.
Nevro provides Senza System , a Spinal Cord Stimulator (SCS), and its proprietary HF10 Therapy , an advanced SCS therapy that provides spinal cord electrical pulses at 10 kHz per second. Compared with traditional SCS, It can be stimulated with a lower frequency between 40 Hz and 60 Hz, and it can also alleviate the paresthesia of back and leg pain. Electric pulse is a generator with very small electrodes implanted under the skin close to the spinal cord. Its rechargeable battery has a battery life of at least 10 years and meets CE standards.
Nevro Corp. sells its products through its direct sales department, as well as a network of sales agents and independent distributors.